Of interest, different populations of CD8+ cells, if subtyped by the expression level of programmed cell death protein 1, provide different anti-cancer activity against NSCLC cells, as shown in cultured cells [106]. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.